Showing results 1 to 2 of 2
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Rationale and design of the TEMPO (tolvaptan efficacy and safety in management of autosomal dominant polycystic kidney disease and its outcomes) 3-4 study Journal:American Journal of Kidney Diseases | 2011 | ||
Tolvaptan in autosomal dominant polycystic kidney disease: Three years' experience Journal:Clinical Journal of the American Society of Nephrology | 2011 |